Clinical trial RESGEX
Randomized, controlled, open-label, multicenter, phase II study to evaluate the efficacy and safety of CetuGEXTM plus chemotherapy in comparison to cetuximab plus chemotherapy for the treatment of patients with stage III/IV recurrent and/or metastatic squamous cell carcinoma of the head and neck
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Glycotope |
| EudraCT Identifier | 2013-003695-13 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02052960 |
| Inclusion criteria | EGFR+ |
| Last update |